SEC Form 4 · accession 0001012975-18-000866
AILERON THERAPEUTICS INC · ALRN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
APPLE TREE PARTNERS II LP
10% Owner
Period of report
Jun 22, 2018
Accepted (ET)
Jun 26, 2018 · 6:15 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001420565
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Jun 22, 2018 | S | 94,816 | $5.9773 | D | 1,391,682 | D | |
| Common StockF3,F2 | Jun 25, 2018 | S | 913 | $5.8631 | D | 1,390,769 | D | |
| Common StockF4,F2 | Jun 26, 2018 | S | 10,528 | $5.4545 | D | 1,380,241 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The transaction was executed in multiple trades at prices ranging from $5.66 to $6.12. The price above reflects the weighted average transaction price. Detailed information regarding the number of shares transacted at each separate price will be provided upon request by the Commission staff, the Issuer or a security holder of the Issuer.
- F2Dr. Seth L. Harrison is the general partner of Apple Tree Ventures II, L.P., the general partner of Apple Tree Partners II, L.P., and Dr. Harrison disclaims beneficial ownership of the shares held by Apple Tree Partners II, L.P., except to the extent of his pecuniary interest therein. Dr. Harrison has sole voting and investment power over the shares held by Apple Tree Partners II, L.P.
- F3The transaction was executed in multiple trades at prices ranging from $5.75 to $6.00. The price above reflects the weighted average transaction price. Detailed information regarding the number of shares transacted at each separate price will be provided upon request by the Commission staff, the Issuer or a security holder of the Issuer.
- F4The transaction was executed in multiple trades at prices ranging from $5.30 to $5.75. The price above reflects the weighted average transaction price. Detailed information regarding the number of shares transacted at each separate price will be provided upon request by the Commission staff, the Issuer or a security holder of the Issuer.